FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and applies to pharmaceutical formulations, which contain human recombinant alfa-2 interferon used to prevent and treat the viral and different infections with immunodeficiency. The pharmaceutical agent, applied for patent, is made as rectal suppository, which contains the human recombinant alfa-2 interferon, antioxidant complex, as well as a substance that promotes the expression of interferon receptors at mononuclear leucocytes of peripheral blood and hepatocytes, and the substance, which promotes complete release of interferon from suppository and its absorption per rectum. The pharmaceutical agent can also contain hepatoprotector and additional antioxidant.
EFFECT: invented pharmaceutical agent is highly efficient in interferon therapy of different viral diseases.
6 cl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIAL, ANTIOXIDATING, MEMBRANE STABILISING, ANTI-INFLAMMATORY, ANTITOXIC MEDICINAL AGENT FOR INFLAMMATORY-INFECTIOUS DISEASES | 2007 |
|
RU2327486C1 |
| HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
| MEDICINE WITH IMMUNE MODIFYING, ANTIVIRUS, ANTIBACTERIAL ANTIOXIDISING, MEMBRANE STABILISING, CARTILAGE AND CONNECTIVE TISSUE GROWTH STIMULATING EFFECT | 2007 |
|
RU2349339C1 |
| PROLONGED INTERFERON SOLUTION | 2004 |
|
RU2270692C1 |
| STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
| AGENT FOR SEVERE INFECTIOUS DISEASES AND MIXED INFECTIONS | 2008 |
|
RU2366450C1 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
| CURATIVE AGENT | 2005 |
|
RU2283133C1 |
| RECTAL SUPPOSITORIES AND DEVICE FOR INTRODUCTION THEREOF | 1991 |
|
RU2024253C1 |
| RECTAL SUPPOSITORY MEDICINAL PRODUCT AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2689320C1 |
